arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Ispire Technology Inc.

ISPR Health Care Medicinal Chemicals and Botanical Products
$1.66
Today
as of Jul 22, 16:50 ET
Last 30 days +3.75% Jun 12 → Jul 22
$1.03 $1.28 $1.54 $1.80 $2.05 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$1.67
High
$1.72
Low
$1.62
Volume
$88,590
Avg Vol
$72,260
Mkt Cap
$103M
P/E (TTM)
—
Beta
—
52w High
$3.87
52w Low
$1.19
Div Yield
—
Shares Out
$57M

Recent Press Releases & News last 60 days · 1 item

Jul 22 · 11:08 MT Newswires
--BTIG Research Initiates Ispire Technology With Buy Rating, $3.50 Price Target

Overview

52-week range
$1.19
$3.87
18% of range
Avg surprise (last 2)
-404.2%
Avg reaction (last 2)
+7.3%
100% positive
Latest IV / EM
553%
EM ±126.5% · $3 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.19$-0.15$-0.10$-0.06$-0.02 Actual $-0.02Actual $-0.07Actual $-0.11Actual $-0.10Actual $-0.14Actual $-0.19Est $-0.12Actual $-0.06Actual $-0.12Actual $-0.17Est $-0.02 SepDecMarSepDecMar/2025SepDecMar/2026
Revenue vs Net Income Revenue Net income
$-11M$3M$17M$30M$44M Sep 24Dec 24Mar 25Sep 25Dec 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.17 $-0.02 -750.0% +10.5% +10.1% earnings
Wed Dec 31, 2025Dec 2025 $-0.12 — — — — financials
Tue Sep 30, 2025Sep 2025 $-0.06 — — — — financials
Fri May 9, 2025Mar/2025 $-0.19 $-0.12 -58.3% — +4.5% earnings
Tue Dec 31, 2024Dec 2024 $-0.14 — — — — financials
Mon Sep 30, 2024Sep 2024 $-0.10 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.11 — — — — financials
Sun Dec 31, 2023Dec 2023 $-0.07 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.02 — — — — financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$19M$20M$30M—$26M$42M$39M—
Cost of revenue$17M$17M$25M—$21M$34M$32M—
Gross profit$2M$3M$5M—$5M$8M$8M—
Operating income$-9M$-7M$-3M—$-11M$-7M$-5M—
Net income$-10M$-7M$-3M—$-11M$-8M$-6M—
EPS (diluted)$-0.17$-0.12$-0.06—$-0.19$-0.14$-0.10—

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$18M$18M$23M$24M$24M$34M$38M$35M
Inventory$5M$5M$6M$7M$8M$8M$7M$6M
Total current assets$56M$64M$75M$73M$94M$112M$109M$103M
Total assets$76M$84M$96M$102M$116M$132M$129M$123M
Long-term debt————————
Total liabilities$92M$92M$98M$102M$101M$108M$98M$88M
Total equity$-16M$-8M$-2M$604,694$15M$24M$31M$34M

Implied volatility — last 90 days

279%1352%2425%3497%4570% Jun 07 — IV 1423% · EM ±197.1%Jun 08 — IV 1572% · EM ±207.6%Jun 09 — IV 1429% · EM ±179.0%Jun 10 — IV 1015% · EM ±119.9%Jun 11 — IV 1710% · EM ±189.0%Jun 12 — IV 1588% · EM ±162.5%Jun 15 — IV 1365% · EM ±98.7%Jun 16 — IV 1796% · EM ±106.1%Jun 17 — IV 4570% · EM ±190.9%Jun 19 — IV 280% · EM ±61.9%Jun 22 — IV 282% · EM ±58.8%Jun 23 — IV 461% · EM ±94.4%Jun 24 — IV 453% · EM ±90.7%Jun 25 — IV 362% · EM ±71.0%Jun 26 — IV 714% · EM ±136.7%Jun 29 — IV 1073% · EM ±190.1%Jun 30 — IV 1970% · EM ±339.3%Jul 01 — IV 2363% · EM ±394.7%Jul 02 — IV 2136% · EM ±345.5%Jul 03 — IV 2211% · EM ±345.5%Jul 06 — IV 2740% · EM ±379.5%Jul 07 — IV 3098% · EM ±409.1%Jul 08 — IV 1516% · EM ±189.9%Jul 09 — IV 1831% · EM ±216.3%Jul 10 — IV 2082% · EM ±230.1%Jul 13 — IV 1706% · EM ±142.5%Jul 14 — IV 1382% · EM ±100.0%Jul 15 — IV 2792% · EM ±164.9%Jul 16 — IV 3694% · EM ±154.3%Jul 20 — IV 443% · EM ±104.5%Jul 21 — IV 911% · EM ±211.8%Jul 22 — IV 553% · EM ±126.5%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in